Last filing: May 13, 2026. Most recent sale before this period: Mar 14, 2022. Most recent purchase on record: Feb 20, 2025.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Mar 14, 2022.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Colgate-Palmolive (CL) | Director | May 13, 2026 | May 13, 2026 |
| Bristol Myers Squibb (BMY) | Chief Executive Officer, Director | Sep 6, 2018 | Mar 12, 2026 |
Also a director at
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 11, 2026, Colgate-Palmolive: 1,383 shares awarded. 1 filing: 1
- Mar 10, 2026, Bristol Myers Squibb: 71,537 shares vested; 30,039 shares in other transactions; 21,229 shares withheld by the company for taxes. 1 filing: 1
- Nov 1, 2025, Bristol Myers Squibb: 2,964 shares vested; 544 shares in other transactions; 1,238 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.